m+Medelevator.RU
← Поиск публикаций
BMC sports science, medicine & rehabilitation · 2026

Exercise intervention improves the modified Barthel index, Berg balance scale, and Fugl-Meyer assessment of upper limb motor function in stroke patients: a systematic review and meta-analysis.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zou Zihan, Liu Yanjun, Zhang Ziyi, Zhao Ran, Gu Lei

Аннотация

BACKGROUND AND OBJECTIVE: Exercise is a core approach in stroke rehabilitation, yet updated evidence on its effects on the Berg balance scale (BBS), modified Barthel index (MBI), and Fugl-Meyer assessment of upper extremity motor function (FMA-UE) remains limited. This study systematically evaluated the effects of exercise interventions on these three outcomes.

METHODS: PubMed, Web of Science, Cochrane Library, and China National Knowledge Infrastructure (CNKI) were searched from January 2015 to March 2025 for randomized controlled trials. Meta-analysis was performed using RevMan 5.4, and a meta-regression analysis was performed to explore the dose‒response relationship between exercise dose and improvements in FMA-UE scores. The minimal clinically important difference (MCID) was used to derive an optimal dose threshold.

RESULTS: Nineteen RCTs involving 1,041 participants were included. Exercise significantly improved the MBI (SMD = 0.95, 95% CI: 0.42-1.49), BBS (SMD = 0.73, 95% CI: 0.24-1.22), and FMA-UE (SMD = 0.62, 95% CI: 0.16-1.07) scores. The meta-regression analysis revealed a linear relationship (MD = 1.5252 + 0.0003 × total dose). The optimal dose threshold for achieving an MCID of 5 points was approximately 11,580 min (193 h).

CONCLUSIONS: Exercise improves balance, daily activities, and upper limb function in stroke patients. The proposed "193-hour concept" provides a preliminary cumulative dose target for clinically meaningful upper limb recovery, pending prospective validation. PROSPERO registration: CRD420251272336.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты